NDC 52959-540
CELEBREX
Celecoxib
CELEBREX is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by H.j. Harkins Company, Inc.. The primary component is Celecoxib.
| Product ID | 52959-540_fa8f4605-2a86-49f2-8a42-d706ce01a5b0 |
| NDC | 52959-540 |
| Product Type | Human Prescription Drug |
| Proprietary Name | CELEBREX |
| Generic Name | Celecoxib |
| Dosage Form | Capsule |
| Route of Administration | ORAL |
| Marketing Start Date | 1998-10-02 |
| Marketing Category | NDA / NDA |
| Application Number | NDA020998 |
| Labeler Name | H.J. Harkins Company, Inc. |
| Substance Name | CELECOXIB |
| Active Ingredient Strength | 100 mg/1 |
| Pharm Classes | Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] |
| NDC Exclude Flag | E |
| Listing Certified Through | 2017-12-31 |
Packaging
NDC 52959-540-30
30 CAPSULE in 1 BOTTLE (52959-540-30)
| Marketing Start Date | 1998-10-02 |
| NDC Exclude Flag | N |
| Sample Package? | N |
NDC SPL Data Element Entries
NDC 52959-540-30 [52959054030]
CELEBREX CAPSULE
| Marketing Category | NDA |
| Application Number | NDA020998 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 1998-10-02 |
| Inactivation Date | 2019-11-13 |
NDC 52959-540-40 [52959054040]
CELEBREX CAPSULE
| Marketing Category | NDA |
| Application Number | NDA020998 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 1998-10-02 |
| Inactivation Date | 2019-11-13 |
NDC 52959-540-15 [52959054015]
CELEBREX CAPSULE
| Marketing Category | NDA |
| Application Number | NDA020998 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 1998-10-02 |
| Inactivation Date | 2019-11-13 |
NDC 52959-540-14 [52959054014]
CELEBREX CAPSULE
| Marketing Category | NDA |
| Application Number | NDA020998 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 1998-10-02 |
| Inactivation Date | 2019-11-13 |
NDC 52959-540-20 [52959054020]
CELEBREX CAPSULE
| Marketing Category | NDA |
| Application Number | NDA020998 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 1998-10-02 |
| Inactivation Date | 2019-11-13 |
NDC 52959-540-21 [52959054021]
CELEBREX CAPSULE
| Marketing Category | NDA |
| Application Number | NDA020998 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 1998-10-02 |
| Inactivation Date | 2019-11-13 |
NDC 52959-540-28 [52959054028]
CELEBREX CAPSULE
| Marketing Category | NDA |
| Application Number | NDA020998 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 1998-10-02 |
| Inactivation Date | 2019-11-13 |
Drug Details
Active Ingredients
| Ingredient | Strength |
|---|---|
| CELECOXIB | 100 mg/1 |
OpenFDA Data
| SPL SET ID: | b6bd0101-ebf0-43e8-99bf-21cb032b05d6 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| PHarm Class EPC | |
| NUI Code |
Pharmacological Class
- Cyclooxygenase Inhibitors [MoA]
- Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient]
- Nonsteroidal Anti-inflammatory Drug [EPC]
NDC Crossover Matching brand name "CELEBREX" or generic name "Celecoxib"
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0025-1515 | CELEBREX | Celecoxib |
| 0025-1520 | CELEBREX | Celecoxib |
| 0025-1525 | CELEBREX | Celecoxib |
| 0025-1530 | CELEBREX | Celecoxib |
| 68387-552 | CELEBREX | CELEBREX |
| 68788-0768 | CELEBREX | CELEBREX |
| 21695-023 | CELEBREX | CELEBREX |
| 21695-022 | CELEBREX | CELEBREX |
| 33261-019 | CELEBREX | CELEBREX |
| 49999-383 | CELEBREX | CELEBREX |
| 52959-540 | CELEBREX | CELEBREX |
| 52959-539 | CELEBREX | CELEBREX |
| 55154-3621 | CELEBREX | CELEBREX |
| 55154-3622 | CELEBREX | CELEBREX |
| 55289-451 | CELEBREX | CELEBREX |
| 55154-3625 | CELEBREX | CELEBREX |
| 55289-475 | CELEBREX | CELEBREX |
| 61919-046 | CELEBREX | CELEBREX |
| 63187-079 | CELEBREX | CELEBREX |
| 63629-6368 | CELEBREX | CELEBREX |
| 63629-3021 | CELEBREX | CELEBREX |
| 66336-940 | CELEBREX | CELEBREX |
| 67544-204 | CELEBREX | CELEBREX |
| 80425-0096 | Celebrex | Celebrex |
| 80425-0038 | Celebrex | Celebrex |
| 80425-0040 | Celebrex | Celebrex |
| 80425-0037 | Celebrex | Celebrex |
| 80425-0039 | Celebrex | Celebrex |
| 0093-7165 | Celecoxib | Celecoxib |
| 0093-7166 | Celecoxib | Celecoxib |
| 0093-7170 | Celecoxib | Celecoxib |
| 0093-7306 | Celecoxib | Celecoxib |
Trademark Results [CELEBREX]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 CELEBREX 88814821 not registered Live/Pending |
G. D. Searle LLC 2020-02-28 |
 CELEBREX 75655826 2321622 Live/Registered |
G. D. SEARLE LLC 1999-03-08 |
 CELEBREX 75432043 2307888 Live/Registered |
G. D. SEARLE LLC 1998-02-10 |
© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.